Tag: FDA

Posted on

New Brunswick Giant Johnson & Johnson Downplays the Severity of Benzene Contamination in Sunscreen

external content.duckduckgo 24

Founded in 1886 in New Brunswick, New Jersey, Johnson & Johnson has become the largest healthcare corporation in the world over the decades, with 250 subsidiary companies operating in 60 countries. However, the company has been the subject of controversy many times. For instance, while Johnson & Johnson had known that the talc in its famous baby powder was contaminated with asbestos since the ‘70s, the company decided to keep this a secret from consumers. Consequently, thousands of people came to struggle with ovarian cancer and mesothelioma, a sporadic and aggressive cancer of the lungs, several decades later. Johnson & Johnson had to pay millions of dollars to the victims in over 40,000 cases.

Continue reading New Brunswick Giant Johnson & Johnson Downplays the Severity of Benzene Contamination in Sunscreen

Posted on

Fresh Cut fruit, Vegetables sold at Wegmans, Other Stores Recalled Over Listeria Concerns

external content.duckduckgo 41

the staff of the Ridgewood blog

Montvale NJ, Fruit Fresh Up, Inc. is voluntarily recalling from the market all fresh cut fruit and vegetable products and ready to eat dips, sold at Wegmans as listed below, processed at its Depew, NY production facilities, due to a possible health risk from Listeria monocytogenes.

Continue reading Fresh Cut fruit, Vegetables sold at Wegmans, Other Stores Recalled Over Listeria Concerns

Posted on

LEGALIZATION IS DRIVING THE CANNABIS GLOBAL MARKET

external content.duckduckgo 23

During the lockdown, consumers could not visit cannabis shops. The cannabis industry is heavily using social media and e-commerce platforms to reach consumers this year. Many cannabis products such as easy grow cannabis seeds become more popular as a result of the campaign.

Continue reading LEGALIZATION IS DRIVING THE CANNABIS GLOBAL MARKET

Posted on

Researchers Question Reliability of at-home Rapid Antigen Tests

external content.duckduckgo 16
the staff of the Ridgewood blog
Ridgewood NJ, as the SARS-CoV-2 virus mutates over time, changes in its genetic makeup could impact the ability of certain tests to recognize and detect viral antigens. A preprint study posted to medRxiv this week raises questions about the reliability of at-home rapid antigen tests in the early days of infection with the highly mutated Omicron variant of concern (VOC). The small real-world study, which is not yet peer-reviewed, examined test results from 30 people who, because of their workplace rules, were undergoing both rapid antigen and polymerase chain reaction (PCR) tests on a daily basis. On days 0 and 1 following a positive PCR test, both of the at-home rapid antigen tests in use—Abbott BinaxNOW and Quidel QuickVue—produced false-negative results despite the presence of viral loads high enough for transmission. The researchers confirmed that 4 cases transmitted the virus between false-negative test results and noted there likely were more transmissions that were unconfirmed. On average, it took 3 days for people to test positive on a rapid antigen test after testing positive on a PCR test. The researchers shared their results with US CDC and US FDA officials and called for the real-world performance of rapid antigen tests to be reassessed for each new VOC.

Continue reading Researchers Question Reliability of at-home Rapid Antigen Tests

Posted on

Oral Antivirals Could Transform the Treatment of COVID-19

external content.duckduckgo 31

the staff of the Ridgewood blog

Ridgewood NJ, Oral antivirals could transform the treatment of COVID-19, allowing some patients to take medicines while recovering at home instead of having to visit health clinics or be admitted to hospital to receive injections or infusions of currently available therapies. Pfizer this morning released final analysis of its oral antiviral candidate PAXLOVID (the protease inhibitors nirmatrelvir and ritonavir, taken together), showing the treatment retained its 89% efficacy in preventing hospitalization and death among 2,246 high-risk COVID-19 patients.

Continue reading Oral Antivirals Could Transform the Treatment of COVID-19

Posted on

Coca-Cola Recalls 3 Minute Maid Drinks Due To Potential Foreign Objects in the Containers

external content.duckduckgo 26

the staff of the Ridgewood blog

Ridgewood NJ, according to RTTNews Coca Cola Company (KO) has reportedly recalled some of its Minute Maid drinks due to potential foreign objects in the containers, specifically metal bolts or washers.

Continue reading Coca-Cola Recalls 3 Minute Maid Drinks Due To Potential Foreign Objects in the Containers

Posted on

Surgeons at Duke University Implant a New Generation of Total Artificial Heart

external content.duckduckgo 1

 

the staff of the Ridgewood blog

Ridgewood NJ, surgeons at Duke University were the first to implant a new generation of Total Artificial Heart (TAH) after receiving FDA approval for human trials. The TAH has a variable heart rate that adjusts based on patient activity and can be used as a complete replacement for living donor hearts. Each device costs around $190,000, plus the costs of critical care staff and other medications. The device could solve long waitlists and high costs so that a heart will always be available for any patient in need.

Posted on

Pfizer Requests Emergency Authorization for its Oral Antiviral Oral COVID-19 Treatment

Pfizer Logo

the staff of the Ridgewood blog

Ridgewood NJ, Pfizer requested emergency authorization for its antiviral oral COVID-19 treatment on Tuesday after a study found the pills dramatically reduced the risk of hospitalization.

Continue reading Pfizer Requests Emergency Authorization for its Oral Antiviral Oral COVID-19 Treatment

Posted on

FDA has issued a recall for batches of Ellume’s at-home COVID-19 test kits

c9215d4f 47bf 4fbe ad5a 570047c8daf0

the staff of the Ridgewood blog

Ridgewood NJ, The FDA has issued a recall for additional batches of Australia-based company Ellume’s at-home COVID-19 test kits for potentially false-positive results. This recall is for the same issue that was previously reported in early October and classified as a Class I recall, the most serious recall designation that may result in “serious adverse health consequences or death.” Product batches with a manufacture date between February 24 and August 11, 2021, and distribution dates between April 13 and August 26, 2021, are included in the recall, which includes more than 2.2 million of the 3.5 million tests shipped to the US; Ellume’s previous estimate of faulty tests was 427,000. Those who attempt to use the affected tests will be notified through the app of the recall status, and replacement tests can be requested online. Thus far, the FDA has received reports of 35 false positives from the tests.

Continue reading FDA has issued a recall for batches of Ellume’s at-home COVID-19 test kits

Posted on

Dole Announces Precautionary Limited Recall of Garden Classic Salads

external content.duckduckgo

Possible Contamination with Listeria monocytogenes

the staff of the Ridgewood blog

Monterey CA, Dole Fresh Vegetables, Inc. is voluntarily recalling a limited number of cases of garden salad due to a possible health risk from Listeria monocytogenes. Dole Fresh Vegetables is coordinating closely with regulatory officials. No illnesses connected to any of the recalled lot codes have been reported to date. The products being recalled are:

Continue reading Dole Announces Precautionary Limited Recall of Garden Classic Salads

Posted on

Pharmaceutical companies are pushing to develop more effective, easily administered therapeutics for COVID-19

Assay portal scaled
the staff of the Ridgewood blog
Ridgewood NJ, Pharmaceutical companies are pushing to develop more effective, easily administered therapeutics for COVID-19, some of which are being studied for the prevention of SARS-CoV-2 infection. This morning, Merck announced that its investigational oral antiviral molnupiravir, which is being developed with Ridgeback Biotherapeutics, significantly reduced the risk of hospitalization or death among non-hospitalized adult COVID-19 patients with mild-to-moderate symptoms who were considered high risk due to other health conditions such as obesity, diabetes, or heart disease. Among patients who took a 5-day course of the drug, 7.3% (28/385) were hospitalized or died compared with 14.1% (53/377) of patients who took a placebo, according to the interim analysis of the Phase 3 MOVe-OUT trial. Merck said it will file an application for Emergency Use Authorization (EUA) with the US FDA as soon as possible, as well as filing applications for marketing with regulatory agencies globally. Over the summer, the US government announced plans to purchase 1.7 million courses of molnupiravir from Merck for about US$1.2 billion, pending US FDA authorization or approval. If authorized, the drug would become the first oral medication available to treat COVID-19.

Continue reading Pharmaceutical companies are pushing to develop more effective, easily administered therapeutics for COVID-19

Posted on

The FDA Say NO to Booster Shots , Except for Over 65 High Risk Individuals

external content.duckduckgo 51

the staff of the Ridgewood blog

Washington DC, The Food and Drug Administration advisory committee on Friday rejected a proposal to distribute booster shots of Pfizer and BioNTech’s Covid-19 vaccines to the general public, paring back those plans to unanimously recommend the third shots to people age 65 and older and other vulnerable Americans.

Continue reading The FDA Say NO to Booster Shots , Except for Over 65 High Risk Individuals

Posted on

Infectious disease expert, “Using ivermectin, an anti-parasitic drug, to treat or prevent COVID-19 is up there with swallowing bleach”

Ivermectin

the staff of the Ridgewood blog

Hackensack NJ, Using ivermectin, an anti-parasitic drug, to treat or prevent COVID-19 is up there with swallowing bleach and blow drying your face, it does not work and can cause serious harm.

Continue reading Infectious disease expert, “Using ivermectin, an anti-parasitic drug, to treat or prevent COVID-19 is up there with swallowing bleach”

Posted on

FDA Renewed its Warning that the Anti-parasitic Animal drug Ivermectin, “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”

Ivermectin

the staff of the Ridgewood blog

Ridgewood NJ, over the weekend, the US FDA renewed its warning that the anti-parasitic animal drug ivermectin should not be used to treat or prevent SARS-CoV-2 infection in humans. The FDA’s message appeared on Twitter with the statement “You are not a horse. You are not a cow. Seriously, y’all. Stop it.” The tweet linked to the agency’s previous statement posted in March 2021. The reiterated warning came a day after the Mississippi State Department of Health issued an alert warning people against using the drug.

Continue reading FDA Renewed its Warning that the Anti-parasitic Animal drug Ivermectin, “You are not a horse. You are not a cow. Seriously, y’all. Stop it.”

Posted on

CDC : People who are moderately to severely immunocompromised are especially vulnerable to COVID-19

external content.duckduckgo 35

the staff of the Ridgewood blog

Ridgewood NJ, the CDC now says people who are moderately to severely immunocompromised are especially vulnerable to COVID-19 because they are more at risk of serious, prolonged illness. Studies indicate some immunocompromised people don’t always build the same level of immunity after vaccination the way non-immunocompromised people do.

CDC recommends that people with moderately to severely compromised immune systems receive an additional dose of mRNA COVID-19 vaccine at least 28 days after a second dose of Pfizer-BioNTech COVID-19 vaccine or Moderna COVID-19 vaccine.

Continue reading CDC : People who are moderately to severely immunocompromised are especially vulnerable to COVID-19